Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study

This retrospective observational study (NEUF) included adult patients with B-cell acute lymphoblastic leukemia (B-cell ALL) who had received blinatumomab for the treatment of minimal residual disease-positive (MRD+) or relapsed/refractory (R/R) B-cell ALL via an expanded access program (EAP). Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Boissel, Nicolas, Chiaretti, Sabina, Papayannidis, Cristina, Ribera, Josep-Maria, Bassan, Renato, Sokolov, Andrey N., Alam, Naufil, Brescianini, Alessandra, Pezzani, Isabella, Kreuzbauer, Georg, Zugmaier, Gerhard, Foà, Robin, Rambaldi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813344/
https://www.ncbi.nlm.nih.gov/pubmed/36599847
http://dx.doi.org/10.1038/s41408-022-00766-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813344/
https://www.ncbi.nlm.nih.gov/pubmed/36599847
http://dx.doi.org/10.1038/s41408-022-00766-7

Ejemplares similares